Jiulu Zhao, Shuan Ran, Sijie Zhou, Yuan Li, Wang Zhan, Longyong Lai et al. MEK1/2 Signalling establishes an alloreactive effector T cell program through SMAD4 during cardiac allograft rejection. // Clinical and Translational Medicine. – 2026. – DOI: 10.1002/ctm2.70865. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70865?af=R
Jiulu Zhao, Shuan Ran, Sijie Zhou, Yuan Li, Wang Zhan, Longyong Lai, Jikai Cui, Jiahong Xia, & Jie Wu (2026). MEK1/2 Signalling establishes an alloreactive effector T cell program through SMAD4 during cardiac allograft rejection. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70865
Jiulu Zhao, et al. “MEK1/2 Signalling establishes an alloreactive effector T cell program through SMAD4 during cardiac allograft rejection.” Clinical and Translational Medicine, 2026. doi:10.1002/ctm2.70865.
@article{Zhao2026,
title = {MEK1/2 Signalling establishes an alloreactive effector T cell program through SMAD4 during cardiac allograft rejection},
author = {Zhao, Jiulu and Ran, Shuan and Zhou, Sijie and Li, Yuan and Zhan, Wang and Lai, Longyong and Cui, Jikai and Xia, Jiahong and Wu, Jie},
journal = {Clinical and Translational Medicine},
year = {2026},
doi = {10.1002/ctm2.70865},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70865?af=R}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...